CRISPR/Cas9-Based Approaches for Huntington’s Disease: From Lab to Clinic
CRISPR/Cas9 technology offers promising avenues for treating Huntington’s disease, a debilitating neurodegenerative disorder. This article explores the latest advancements in CRISPR/Cas9-based approaches, examining their potential for clinical translation and the challenges that need to be overcome.